PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Appoints Experienced US-Based CEO, page-26

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    He should be quite comfortable then with MPS. Whilst any deal will be modest in comparison to OA, it could happen any time and before we get our hands on the initial read out of 008. Could be exciting Q1 of FY23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.